Final analysis of a randomized phase II trial with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma -PVAG-14 pilot-

Fuchs, M. and Wongso, D. and Pluetschow, A. and Feuring-Buske, M. and Hertenstein, B. and Hoeffkes, H. -G and Vogelhuber, M. and von Tresckow, B. and Biersack, H. and Link, H. and Topp, M. S. and Fischer, N. and Bredenfeld, H. and Sasse, S. and Behringer, K. and Boell, B. and Borchmann, P. and Engert, A. (2014) Final analysis of a randomized phase II trial with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma -PVAG-14 pilot-. ONCOLOGY RESEARCH AND TREATMENT, 37 (Suppl5). p. 11. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 07 Aug 2020 05:58
Last Modified: 07 Aug 2020 05:58
URI: https://pred.uni-regensburg.de/id/eprint/9410

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.